4.5 Article

Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death

Journal

HUMAN MOLECULAR GENETICS
Volume 21, Issue 5, Pages 1138-1144

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddr542

Keywords

-

Funding

  1. Medivation
  2. GSK
  3. Pfizer
  4. National Institutes of Health [AG028679, NS062787]
  5. Alzheimer's Association [NIRG-09-132727]
  6. Dr Robert M. Kohrman Memorial Fund

Ask authors/readers for more resources

In Alzheimer disease (AD), amyloid- (A) oligomer is suggested to play a critical role in imitating neurodegeneration, although its pathogenic mechanism remains to be determined. Recently, the cellular prion protein (PrPC) has been reported to be an essential co-factor in mediating the neurotoxic effect of A oligomer. However, these previous studies focused on the synaptic plasticity in either the presence or the absence of PrPC and no study to date has reported whether PrPC is required for the neuronal cell death, the most critical element of neurodegeneration in AD. Here, we show that Prnp(/) mice are resistant to the neurotoxic effect of A oligomer in vivo and in vitro. Furthermore, application of an anti-PrPC antibody or PrPC peptide prevents A oligomer-induced neurotoxicity. These findings are the first to demonstrate that PrPC is required for A oligomer-induced neuronal cell death, the pathology essential to cognitive loss.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available